Cargando...

Dendritic cell-based immunotherapy in ovarian cancer

Worldwide, 80% of patients with ovarian cancer die of the disease. New treatments for this aggressive disease are therefore being intensively searched. Although dendritic cell-based vaccines against gynecological malignancies are in their infancy, this immunotherapeutic approach holds much promise....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Coosemans, An, Vergote, Ignace, Van Gool, Stefaan W
Formato: Artigo
Lenguaje:Inglês
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913669/
https://ncbi.nlm.nih.gov/pubmed/24501688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27059
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!